Igenomix USA News and Activities

Igenomix USA is owned by Vitrolife.

Vitrolife is a company listed under the stock ticker VITR (SE).

Vitrolife has a direct presence in 2 countries.

View the org chart displaying its 2 main executives

Most searched biographies at Igenomix USA

• Refik Kayali, Lab Director
• Alyssa Snider, Vice President of Clinical Genetic Services

Popular executive movements at Vitrolife

• Ermanno Sironi, Chief Operating Officer, has left the company  (posted on June 2 2026).
• Olivier Desmarets has joined the company as Chief Operating Officer  (posted on June 2 2026).
• David Hansen has joined the company as Director  (posted on May 25 2026).

Click here to view some more movements at Vitrolife

Create your alert
to follow the executive moves at Igenomix USA.

Vitrolife has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Igenomix USA

Social media about Igenomix USA

• Igenomix USA on Wikipedia, Google News & Yahoo Finance
• Igenomix USA on LinkedIn, X (Twitter) & YouTube